Ikuta, K. S. et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 2221–2248 (2022).
Lewnard, J. A. et al. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lancet 403, 2439–2454 (2024).
Kållberg, C. et al. Introduction and geographic availability of new antibiotics approved between 1999 and 2014. PLoS ONE 13, e0205166 (2018).
Article PubMed PubMed Central Google Scholar
African Society for Laboratory Medicine. Policy brief and infographics on antimicrobial resistance (AMR) in Africa. ASLM https://aslm.org/resource/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa/ (2022).
Klein, E. Y. et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. Lancet Infect. Dis. 21, 107–115 (2021).
Kanu, J. S. et al. National antibiotic consumption for human use in Sierra Leone (2017–2019): a cross-sectional study. Trop. Med. Infect. Dis. 6, 77 (2021).
Article PubMed PubMed Central Google Scholar
Namugambe, J. S. et al. National antimicrobial consumption: analysis of central warehouses supplies to in-patient care health facilities from 2017 to 2019 in Uganda. Trop. Med. Infect. Dis. 6, 83 (2021).
Article PubMed PubMed Central Google Scholar
Shukar, S. et al. Drug shortage: causes, impact, and mitigation strategies. Front. Pharmacol. 12, 693426 (2021).
Article CAS PubMed PubMed Central Google Scholar
Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
So, A. D., Ruiz-Esparza, Q., Gupta, N. & Cars, O. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ. 344, e1782 (2012).
留言 (0)